Global Companion Animal Vaccine Market Report and Forecast 2024-2032

Global Companion Animal Vaccine Market Outlook

The global companion animal vaccine market is expected to grow at a CAGR of 6.2% during the period 2024-2032. The market is expected to be driven by the growing rate of adoption of companion animals, including rabbits, dogs, cats, etc. In recent years, some European countries have witnessed a significant increase in pet adoption. Pets or companion animals offer humans much needed interaction that offers social, medical, emotional and physical benefits. North America, Europe and Asia are expected to be key markets.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Market Likely to be Driven by Advancements in Treatment Systems

Differing customer needs across regions characterize the animal health medicines, vaccines and diagnostics market space.  Factors include economic differences (standards of living in developing versus developed nations), cultural differences (including dietary preferences for separate animal proteins, pet ownership preferences and standards of pet care), epidemiological differences (for example, prevalence of particular bacterial and viral strains and aspects of  diseases), treatment differences (utilization of various types of vaccines and medicines, and rate of adoption of novel  technologies), environmental differences (seasonality, climate and the availability of arable land and fresh water), and regulatory differences.

Growth in the companion animal vaccines sector is propelled by economic development, associated increase in disposable income, and rise in pet ownership and expenditure on pet care. Advancements in animal health medicines, vaccines and diagnostics have led to longer lives of companion animals.

Vaccination has been an effective method to decrease disease burden in companion animals, pets and farm animals, and maintaining animal health and welfare. Vaccines play a crucial role in preventative health and disease control programmes in animals. Continual research, innovations and development of safe, effective and quality vaccines have enhanced protection for pets and farm animals. These developments are expected to stimulate the global companion animal vaccine market.

Effective Vaccines Available for Several Important Animal Diseases Likely to Boost Market Growth

Companion animals, pets and farm animals are susceptible to several diseases caused by viruses, bacteria, fungi and parasites. Today, vaccines come for many of these diseases, making it possible to prevent the diseases or minimizing the losses or long-term effects associated with the diseases. This assumes all the more importance when those diseases are considered that are complex, with limited or no available treatment alternatives.

Encouragingly, effective vaccines are nowadays available for several important animal diseases. The animal medicines sector continues to invest in research and development of veterinary vaccines to counter the various types of endemic and exotic diseases. A significant achievement in veterinary medicine in modern times includes the global eradication of a damaging livestock disease – Rinderpest – in 2011; vaccination played a key role therein. Modern veterinary vaccines are a result of several years of research and innovation, and meet multiple disease threats to pets, companion animals and farm animals. Vaccines stimulate immune responses in animals without causing the disease itself.

Main types of existing vaccines may be categorised as follows:

Modified-live (attenuated) – Such a vaccine carries an intact but weakened pathogen; the pathogen stimulates an immune response without causing clinical disease.

Inactivated (killed) – Such a vaccine carries a completely inactivated pathogen (the pathogen is no longer infectious), and generally contains an adjuvant (an added compound to help enhance protective immune response).

Recombinant – A vaccine produced with the help of genetic engineering technology, employing specific genetic material from a pathogen to make proteins to stimulate an immune response in animals after vaccination.

Toxoid – A vaccine based on inactivated toxins made by pathogens. These vaccines stimulate immunity and offer animals protection against these toxins. Through research and innovation, modern and sophisticated technologies like marker vaccines have been developed.

The development of different types of effective vaccines is expected to boost the global companion animal vaccine market.

Effective Vaccination can Prevent, Control or Alleviate Several Diseases in Companion Animals

Vaccines protect companion animals from a variety of diseases. Effective vaccination can prevent, control or alleviate several diseases in cats, including Feline Panleukopenia/Infectious Enteritis (Feline Panleukopenia or Parvovirus, FPV), Feline Rhinotracheitis (Feline Herpesvirus, FHV), Feline Calicivirus (FCV), Feline Leukaemia Virus (FeLV), Chlamydophila felis, and Feline Rabies, among others.

Significant canine diseases for which vaccines are available include Canine Distemper Virus (CDV), Canine Parvovirus (CPV), Canine Adenovirus (CAV), Canine Leptospira, Canine parainfluenza virus (CPi), Bordetella bronchiseptica, and Canine Rabies, among others.

Vaccines protect rabbits from two serious viral infectious diseases – myxomatosis and rabbit haemorrhagic disease.

Farm animals include species such as cattle, sheep, pigs, poultry, and farmed fish. This implies a wide range of potential disease threats, and vaccines are available to protect these farm animals.

Horses, in the form of companion animals, athletes and breeding stock, are exposed to multiple disease threats, according to their unique circumstances. Important equine vaccines include Equine Influenza, Tetanus, Equine Herpes Virus 1 and 4 (EHV-1 and EHV4), among others.

Global Companion Animal Vaccine Market Segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By vaccines, the market is segmented into:

• Live Attenuated Vaccines
• Inactivated Vaccines 
• Toxoid Vaccines
• Recombinant Vaccines
• Subunit Vaccine
• Conjugate Vaccine
• DNA Vaccine
• Others

By animal type, the market is divided into:

• Feline
• Canine
• Bovine
• Others

By disease, the market is classified into:

• Rabies
• Hepatitis
• Leukemia
• Others

By distribution channel, the market is segmented into:

• Veterinary Clinics
• Veterinary Hospitals 
• Veterinary Research Institutes
• Retail Pharmacies
• Others

By region, the market is classified into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Industry Players in the Global Companion Animal Vaccine Market

The report presents a detailed analysis of the following key players in the market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• Boehringer Ingelheim
• Intervet Inc. (Merck Animal Health)
• Zoetis Services LLC
• Bioveta, a.s.
• Elanco Animal Health Incorporated
• Zoetis Inc
• Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report